These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22328326)

  • 21. Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint.
    Nixon RM; Duffy SW; Fender GR
    BMC Med Res Methodol; 2003 Sep; 3():17. PubMed ID: 14507420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.
    Atkinson AC; Biswas A
    Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2012 Apr; 31(8):701-23. PubMed ID: 22161821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies with group treatments required special power calculations, allocation methods, and statistical analyses.
    Faes MC; Reelick MF; Perry M; Olde Rikkert MG; Borm GF
    J Clin Epidemiol; 2012 Feb; 65(2):138-46. PubMed ID: 21856120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple-objective response-adaptive repeated measurement designs in clinical trials for binary responses.
    Liang Y; Li Y; Wang J; Carriere KC
    Stat Med; 2014 Feb; 33(4):607-17. PubMed ID: 24038318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A course for clinical trial personnel in clinical study designs, randomization, allocation schedules, and interactive response systems.
    Golm GT; Bradstreet TE; Coffey LA
    Pharm Stat; 2011; 10(2):175-82. PubMed ID: 20967893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML; Chinchilli VM
    Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blinded assessment of treatment effects utilizing information about the randomization block length.
    Miller F; Friede T; Kieser M
    Stat Med; 2009 May; 28(12):1690-706. PubMed ID: 19340815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.
    Weir CJ; Lees KR
    Stat Med; 2003 Mar; 22(5):705-26. PubMed ID: 12587101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint.
    Baker SG
    Biostatistics; 2006 Jan; 7(1):58-70. PubMed ID: 15972889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomization procedures in orthopaedic trials.
    Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
    Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Likelihood inference on the relative risk in split-cluster designs.
    Shoukri MM; Colak D; Donner A
    Clin Trials; 2011 Feb; 8(1):37-47. PubMed ID: 21335588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
    Wang SJ; Hung HM; O'Neill R
    J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A consistency-adjusted alpha-adaptive strategy for sequential testing.
    Alosh M; Huque MF
    Stat Med; 2010 Jul; 29(15):1559-71. PubMed ID: 20552571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.
    Verberk WJ; Kroon AA; Kessels AG; Nelemans PJ; Van Ree JW; Lenders JW; Thien T; Bakx JC; Van Montfrans GA; Smit AJ; Beltman FW; De Leeuw PW
    Blood Press; 2005; 14(5):306-14. PubMed ID: 16257877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Start-up designs for response-adaptive randomization procedures with sequential estimation.
    Haines LM; Sadiq H
    Stat Med; 2015 Sep; 34(21):2958-70. PubMed ID: 25944171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.